Stridewell Llc is a
Behavior Analyst based in Austin, Texas. Stridewell Llc is licensed to practice in * (Not Available) (license number ) and their current practice location is
2021 Guadalupe St Ste 260, Austin, Texas. It can be reached at their office (for appointments etc.) via phone at
(225) 443-3645.
NPI number for Stridewell Llc is 1871392381 and their current mailing address is 12856 N Hwy 183 Ste B, #2102, Austin, Texas. Stridewell Llc
does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1871392381.
Healthcare Provider's Profile
Full Name | Stridewell Llc |
---|
Type | Facility |
---|
Speciality | Behavior Analyst |
---|
Location | 2021 Guadalupe St Ste 260, Austin, Texas |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
NPI Data:
- NPI Number: 1871392381
- Provider Enumeration Date: 03/10/2025
- Last Update Date: 06/23/2025
Medical Identifiers
Medical identifiers for Stridewell Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1871392381 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stridewell Llc is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Stridewell Llc 12856 N Hwy 183 Ste B, #2102, Austin, TX 78750-3222 Ph: (225) 443-3645 | Stridewell Llc 2021 Guadalupe St Ste 260, Austin, TX 78705-5654 Ph: (225) 443-3645 |
Reviews and Comments